Literature DB >> 9096363

Folding of the beta-propeller domain of the integrin alphaL subunit is independent of the I domain and dependent on the beta2 subunit.

C Huang1, T A Springer.   

Abstract

We have studied the folding during biosynthesis of the lymphocyte function-associated antigen 1 (LFA-1) alphaL subunit using mAb to epitopes that map to seven different regions within the amino acid sequence. The N-terminal portion of alphaL is predicted to contain a beta-propeller domain, consisting of seven beta-sheets, and an I domain that is predicted to be inserted between beta-sheet 2 and beta-sheet 3 of the beta-propeller. The I domain of alphaL folds before association with the beta2 subunit, as shown by immunoprecipitation of the unassociated alphaL subunit by mAbs specific for four different sequence elements within the I domain. By contrast, the beta-propeller domain is not folded in unassociated alphaL after a chase of as long as 12 h after synthesis, but does fold upon association with beta2. This is shown with mAbs to regions of alphaL, that precede and follow the I domain in the primary structure. A mAb that maps near the junction of the C terminus of the I domain with the beta-propeller domain suggests that this region is partially folded before subunit association. The results show that the I domain and beta-propeller domains fold independently of one another, and suggest that the beta-propeller domain bears an interface for association with the beta subunit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096363      PMCID: PMC20339          DOI: 10.1073/pnas.94.7.3162

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Structural principles for the propeller assembly of beta-sheets: the preference for seven-fold symmetry.

Authors:  A G Murzin
Journal:  Proteins       Date:  1992-10

2.  Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb-IIIa retaining Arg-Gly-Asp binding activity.

Authors:  S C Lam
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

3.  A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells.

Authors:  C Morimoto; C E Rudd; N L Letvin; S F Schlossman
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

4.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

5.  Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency.

Authors:  T K Kishimoto; N Hollander; T M Roberts; D C Anderson; T A Springer
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

6.  Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site.

Authors:  D S Tuckwell; A Brass; M J Humphries
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

7.  Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors.

Authors:  M L Dustin; O Carpen; T A Springer
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

8.  The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.

Authors:  D E Staunton; M L Dustin; H P Erickson; T A Springer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

9.  Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily.

Authors:  R S Larson; A L Corbi; L Berman; T Springer
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Divalent cation regulation of the function of the leukocyte integrin LFA-1.

Authors:  I Dransfield; C Cabañas; A Craig; N Hogg
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  20 in total

1.  Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.

Authors:  B Leitinger; N Hogg
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains.

Authors:  C Lu; M Shimaoka; Q Zang; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking.

Authors:  Shweta Tiwari; Janet A Askari; Martin J Humphries; Neil J Bulleid
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

4.  Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions.

Authors:  Wei Yang; Motomu Shimaoka; JianFeng Chen; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

5.  The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrins.

Authors:  Gabriele Weitz-Schmidt; Thomas Schürpf; Timothy A Springer
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

6.  Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation.

Authors:  W Beau Mitchell; Jihong Li; Marta Murcia; Nathalie Valentin; Peter J Newman; Barry S Coller
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

7.  Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2.

Authors:  JianFeng Chen; Wei Yang; Minsoo Kim; Christopher V Carman; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

8.  Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1.

Authors:  A P Mould; A N Garratt; W Puzon-McLaughlin; Y Takada; M J Humphries
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 9.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

10.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.